breaking

Biotech Firm Eyes Historic Gulf Exchange Listing

Hong Kong-listed pharmaceutical company Insilico Medicine Cayman TopCo is exploring a secondary listing on the Abu Dhabi exchange, according to people with knowledge of the discussions. The potential listing would make it the first company from outside the Gulf to list shares on a regional exchange. Such a move would underscore growing efforts by Middle Eastern exchanges to expand their investor base and compete for cross-border capital. The secondary listing would allow Insilico to access regional funding while maintaining its primary Hong Kong listing. The biotech firm has not publicly confirmed the talks, and no timeline for a potential listing has been disclosed. The transaction would represent a broader trend of emerging markets seeking to attract multinational companies to their exchanges.